consumer info
CT Medicaid rates squeezed a bit but still higher than other states
A new comparison published this month in Health Affairs finds that Connecticut Medicaid provider payment rates lost some ground between 2012 and 2019, but they remain higher than the US average and well above most nearby states. Primary care rates are highest relative to other states than other services. From 2012 to 2019, compared to…
Read MoreWhat does the public really think about a public option? Two polls, and we still don’t know
Dueling polls released this week find Connecticut residents either love the idea of a public health insurance option or they are not big fans. Not surprisingly, the polls are sponsored by groups with dueling agendas and they don’t give details or survey question wording. According to a poll released Monday by Comptroller Kevin Lembo, 71%…
Read MoreHalf of CT hospitals not compliant with new requirement to post negotiated prices for care
Download the report As of January 1st, all US hospitals are required to prominently display on a publicly available website prices privately negotiated with payers for 300 services, under CMS’s Hospital Price Transparency Rule. Hospital “charges” have been available to patients but not the actual prices paid by insurers. CMS requires both a “display of…
Read MoreCTNJ: OP-ED | State Should Set Uniform, Public Standards For Rationing Health Care
Disparities in healthcare are not new in our state, but the pandemic has intensified the unfairness. The aged, people with disabilities, and communities of color have been especially hard hit by the virus and the recession. Unfortunately, a striking example of that increased unfairness is reflected in Connecticut hospitals’ policies for rationing scarce resources during…
Read MoreUnjustified price increases for seven drugs in 2019 cost US healthcare $1.2 billion, CT can remedy this
According to a report released today, in 2019 the US health system spent an extra $1.2 billion on price increases for seven drugs that were not supported by clinical evidence. Enbrel led this year’s list costing Americans $403 million extra for an 8.9% net price increase, after accounting for rebates. The Unsupported Price Increase report…
Read MoreCT got fewer vaccines than other states, but did far better at getting people vaccinated
Download the report here Policymakers and experts have expressed disappointment at the slow rollout of the COVID-19 vaccines. While the vaccines were developed and manufactured at record speeds, getting Americans vaccinated has been slower than expected. The Secretary of Human Services expected to have 20 million Americans vaccinated by the end of 2020. But as…
Read MoreCT housing and economic development training institute now accepting applications
Housing and health are intimately linked. Housing that is unstable, unsafe, poor quality, and a financial burden all affects the health of residents and communities. As these challenges grow, Connecticut’s housing and economic development workforce is predominantly male, white, and growing older. Professionals in the field are retiring at a faster rate than new entries…
Read MoreCTNJ OP-ED | New Health Plan for State Employees Needs Transparency
The State Comptroller’s Office is undertaking payment reform for the very costly state employee health plan without public accountability or transparency. The controversial plan to pay for health care in bundles and reward high quality providers for the plan’s 250,000 members could be a gamechanger, but it could also fail. The problem is that we…
Read MoreCT workers’ health benefits cost more, but growing more slowly and take less of our incomes
Download the report While total premiums, deductibles, and the workers’ share of premiums for Connecticut employee health coverage are higher than the US average, they have generally grown less quickly and consume less of our incomes than for other Americans from 2010 to 2019. Connecticut employer health coverage total premiums, employee share of premiums, and…
Read MoreICER seeking members for New England evidence review group
The Institute for Economic and Clinical Review (ICER) is seeking nominations for new members to the New England Comparative Effectiveness Public Advisory Council (New England CEPAC). The Council includes leading clinicians, patient and consumer advocates, methodologists, and health economists. The group holds public meetings three to four times per year to discuss evidence reports on…
Read More